IP Library › Granted Patent US 8,173,629
Granted Patent B2
US 8,173,629 · App. 12/311,005 · Granted May 8, 2012

Method of treatment using fatty acid synthesis inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,173,629
App. No.
12/311,005
Granted
May 8, 2012
Kind
B2
Abstract

The present invention relates to natural products that possess fatty acid synthesis inhibitor activity and can be used to treat and prevent diseases such as obesity, cancer, diabetes, fungal infections, Mycobacterium tuberculosis infections, malarial infections and other apicomplexan protozoal diseases.

Claims (3)

1. A method of treating Type II diabetes comprising administration to a subject in need thereof a therapeutically effective amount of a compound of formula I or II

or a pharmaceutically acceptable salt thereof,

wherein  represents a bond that can be absent or present.

Assignments (3)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →